Literature DB >> 32339109

Effectiveness of psychological treatments for depressive symptoms among people living with HIV/AIDS in low- and middle-income countries: A systematic review and meta-analysis.

Biksegn Asrat1, Marguerite Schneider2, Fentie Ambaw3, Crick Lund4.   

Abstract

BACKGROUND: Psychological treatments play a significant role in managing depressive symptoms. However, little is known about the most effective psychological treatments for depressive symptoms for people living with HIV/AIDS (PLWHA) in low- and middle-income countries (LMICs). AIMS: To identify effective psychological treatments to manage depressive symptoms for adult PLWHA in LMICs and to estimate pooled effect sizes using a meta-analysis.
METHOD: Four databases were searched using key words and MeSH terms - PubMed, Scopus, Cochrane library and PsychINFO. The inclusion criteria were randomized controlled trials (RCTs) that examine psychological treatments that target depressive symptoms for adult PLWHA in LMICs. The Cochrane risk of bias tool was used to assess the risk of bias. A meta-analysis was done using RevMan-5. RESULT: Nineteen studies were included in the systematic review and 14 of them were selected for meta-analysis. Eight (42%) of the trials used cognitive behavioural therapy (CBT). Pooled effect size of trials that used continuous outcomes was -0.61 (n = 12, 95%CI: -1.24, 0.02, I2 = 95%) at post-treatment assessment. The pooled effect size changed to -1.41 (n = 8, 95%CI: -2.54, -0.28, I2 = 98%) at six months post treatment. LIMITATIONS: Studies varied in quality from low to high risk of bias and there was high heterogeneity across studies.
CONCLUSION: Trials used group support psychotherapy, interpersonal therapy, problem-solving therapy, and peer-support counselling were effective in reducing depressive symptoms. However, better powered studies with more consistent methodologies are needed to investigate whether specific therapies delivered by lay counsellors are effective for PLWHA in LMICs.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depressive symptom; HIV/AIDS; LMICs; Psychological treatment

Year:  2020        PMID: 32339109     DOI: 10.1016/j.jad.2020.03.068

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Results of the Kigali Imbereheza Project: A 2-Arm Individually Randomized Trial of TI-CBT Enhanced to Address ART Adherence and Mental Health for Rwandan Youth Living With HIV.

Authors:  Geri R Donenberg; Jessica Fitts; Charles Ingabire; Sabin Nsanzimana; Mary Fabri; Erin Emerson; Eric Remera; Olivier Manzi; Bethany Bray; Mardge H Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-01       Impact factor: 3.771

2.  Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial.

Authors:  Susan M Meffert; Thomas C Neylan; Charles E McCulloch; Kelly Blum; Craig R Cohen; Elizabeth A Bukusi; Helen Verdeli; John C Markowitz; James G Kahn; David Bukusi; Harsha Thirumurthy; Grace Rota; Ray Rota; Grace Oketch; Elizabeth Opiyo; Linnet Ongeri
Journal:  PLoS Med       Date:  2021-01-11       Impact factor: 11.069

3.  Mental health systems in six Caribbean small island developing states: a comparative situational analysis.

Authors:  Ian F Walker; Laura Asher; Anees Pari; Jennifer Attride-Stirling; Ayoola O Oyinloye; Chantelle Simmons; Irad Potter; Virginia Rubaine; June M Samuel; Aisha Andrewin; Janett Flynn; Arline L McGill; Sharra Greenaway-Duberry; Alicia B Malcom; Gemma Mann; Ahmed Razavi; Roger C Gibson
Journal:  Int J Ment Health Syst       Date:  2022-08-12

4.  The benefits of psychosocial interventions for mental health in men who have sex with men living with HIV: a systematic review and meta-analysis.

Authors:  Yan Yu; Xinyu Wang; Yaxin Wu; Wenjia Weng; Ming Zhang; Juan Li; Xiaojie Huang; Yanqing Gao
Journal:  BMC Psychiatry       Date:  2022-06-29       Impact factor: 4.144

5.  Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease.

Authors:  Steven Paul Woods; Michelle Babicz; Lokesh Shahani; Gabriela Delevati Colpo; Erin E Morgan; Antonio L Teixeira
Journal:  J Neurovirol       Date:  2020-11-03       Impact factor: 2.643

6.  Common mental disorders and HIV status in the context of DREAMS among adolescent girls and young women in rural KwaZulu-Natal, South Africa.

Authors:  Nondumiso Mthiyane; Guy Harling; Natsayi Chimbindi; Kathy Baisley; Janet Seeley; Jaco Dreyer; Thembelihle Zuma; Isolde Birdthistle; Sian Floyd; Nuala McGrath; Frank Tanser; Maryam Shahmanesh; Lorraine Sherr
Journal:  BMC Public Health       Date:  2021-03-10       Impact factor: 3.295

7.  Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda.

Authors:  Noeline Nakasujja; Alyssa C Vecchio; Deanna Saylor; Sarah Lofgren; Gertrude Nakigozi; David R Boulware; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Steven J Reynolds; Thomas C Quinn; Carlos A Pardo; Anupama Kumar; Ronald H Gray; Maria J Wawer; Ned Sacktor; Leah H Rubin
Journal:  J Neurovirol       Date:  2021-07-31       Impact factor: 3.739

8.  Major depressive disorder and its association with adherence to antiretroviral therapy and quality of life: cross-sectional survey of people living with HIV/AIDS in Northwest Ethiopia.

Authors:  Biksegn Asrat; Crick Lund; Fentie Ambaw; Emily Claire Garman; Marguerite Schneider
Journal:  BMC Psychiatry       Date:  2020-09-24       Impact factor: 3.630

9.  Effect of a lay counselor delivered integrated maternal mental health and early childhood development group-based intervention in Siaya County, Kenya: A quasi-experimental longitudinal study.

Authors:  Eunsoo Timothy Kim; Tobias Opiyo; Pauline S Acayo; Margaret Lillie; John Gallis; Yunji Zhou; Michael Ochieng; Samwel Okuro; John Hembling; Elena McEwan; Joy Noel Baumgartner
Journal:  J Affect Disord       Date:  2021-06-13       Impact factor: 4.839

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.